Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Blast Crisis × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

fludarabine phosphate 23 Cyclophosphamide 22 Busulfan 19 Whole-Body Irradiation 18 Peripheral Blood Stem Cell Transplantation 18 Mycophenolic Acid 17 Tacrolimus 13 Cyclosporine 12 Antilymphocyte Serum 12 Methotrexate 10 Melphalan 9 Filgrastim 8 Cytarabine 8 Etoposide 7 Cord Blood Stem Cell Transplantation 7 fludarabine 6 Methylprednisolone 6 Granulocyte Colony-Stimulating Factor 5 thymoglobulin 4 Thiotepa 4 Sirolimus 4 Rituximab 4 Radiotherapy 4 Imatinib Mesylate 4 Flow Cytometry 4 Dexamethasone 4 Cyclosporins 4 Calcium Dobesilate 4 dexamethasone acetate 3 dexamethasone 21-phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡